Terra Nova Asset Management LLC Invests $461,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Terra Nova Asset Management LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 876 shares of the healthcare conglomerate’s stock, valued at approximately $461,000.

A number of other large investors have also recently made changes to their positions in UNH. State Street Corp boosted its position in shares of UnitedHealth Group by 1.7% during the second quarter. State Street Corp now owns 46,313,751 shares of the healthcare conglomerate’s stock valued at $22,260,241,000 after purchasing an additional 764,872 shares in the last quarter. Wellington Management Group LLP boosted its holdings in UnitedHealth Group by 2.1% in the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares in the last quarter. Morgan Stanley raised its holdings in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after buying an additional 1,893,192 shares during the last quarter. Moneta Group Investment Advisors LLC boosted its stake in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its stake in UnitedHealth Group by 3.5% during the 2nd quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock valued at $5,647,433,000 after acquiring an additional 399,739 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Bank of America reaffirmed a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 7th. Stephens restated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 8th. Oppenheimer reiterated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Piper Sandler lowered their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 19th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

UnitedHealth Group Trading Up 0.3 %

Shares of UnitedHealth Group stock opened at $494.70 on Friday. The stock has a market cap of $456.08 billion, a PE ratio of 20.75, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The firm has a fifty day moving average price of $503.10 and a 200 day moving average price of $518.61. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. During the same period in the prior year, the firm posted $5.34 earnings per share. The firm’s quarterly revenue was up 14.1% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.